scispace - formally typeset
K

Katrin Mende

Researcher at Uniformed Services University of the Health Sciences

Publications -  105
Citations -  2185

Katrin Mende is an academic researcher from Uniformed Services University of the Health Sciences. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 22, co-authored 82 publications receiving 1733 citations. Previous affiliations of Katrin Mende include Henry M. Jackson Foundation for the Advancement of Military Medicine & San Antonio Military Medical Center.

Papers
More filters
Journal ArticleDOI

Biofilm formation by clinical isolates and the implications in chronic infections

TL;DR: In patients with relapsing infections, the majority of serial isolates recovered from these individuals were observed to be strong biofilm producers in vitro, and strains from patients with persistent infections are positive for biofilm formation.
Journal ArticleDOI

Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis.

TL;DR: It is found that biofilm production by clinical strains is significantly associated with the persistence of wound infections, and the statistical power of the analysis was limited due to the small sample size, precluding a multivariate analysis.
Journal ArticleDOI

Aminoglycoside Resistance and Susceptibility Testing Errors in Acinetobacter baumannii-calcoaceticus Complex

TL;DR: Studying the susceptibilities of 107 isolates of the Acinetobacter baumannii-calcoaceticus complex to amikacin, gentamicin, and tobramycin found the presence of the ant(2")-Ia gene was statistically associated with resistance to each aminoglycoside.
Journal ArticleDOI

Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients

TL;DR: Despite several methods to test bacteria for topical susceptibility, no defined breakpoints exist and standards need to be established, which means continuing to use silver products for prophylaxis against gram-negatives and mafenide acetate for treatment, and mupirocin for MRSA.